Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in a North Indian population

International Journal of Gynecological Cancer

Volumn 20, Issue 4, 2010, Pages 625-630

  Pandey, Saumya ^a   Mittal, Rama Devi ^a   Srivastava, Madhu ^b   Srivastava, Kirti ^b   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cervical cancer; Cyclooxygenase 2; Genetics; North India; Susceptibility

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEQUENCE ANALYSIS; SMOKING; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; CYCLOOXYGENASE 2; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 77952255595     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181c63f79     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
2. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
3. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-265. (Pubitemid 34293391)
4. Munkarah A, Ali-Fehmi R. COX-2: a protein with an active role in gynecological cancers. Curr Opin Gynecol Oncol. 2005;17:49-53.
5. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta. 1995;1299:125-140.
6. Ryu HS, Chang KH, Yang HW, et al. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol. 2000;76:320-325.
7. Klimp AH, Hollema H, Kempinga C, et al. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. 2001;61:7305-7309.
8. Dore M, Cote LC, Mitchell A, et al. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J Histochem Cytochem. 1998;46:77-84.
9. Kosaka T, Miyata A, Ihara H, et al. Characterization of the human gene (PTGS2) encoding prostaglandinYendoperoxide synthase 2. Eur J Biochem. 1994;221:889-897. (Pubitemid 24146188)
10. Cok SJ, Morrison AR. The 3'-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem. 2001;276:23179-23185.
11. Fritsche E, Baek SJ, King LM, et al. Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther. 2001;299:468-476.
12. Papafili A, Hill MR, Brull DJ, et al. Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol. 2002;22:1631-1636.
13. Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;1116:1215.
14. Hu Z, Miao X, Ma H, et al. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer. 2005;48:11-17. (Pubitemid 40380996)
15. Zhang X, Miao X, Tan W, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology. 2005;129:565-576.
16. Schneider S, Roessli D, Excoffier L. Arlequin ver. 2.000: A Software for Population Genetics Data Analysis [User Manual]. Geneva, Switzerland: Genetics and Biometry Laboratory, University of Geneva; 2000.
17. Lee TS, Jeon YT, Kim JW, et al. Lack of association of cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population. Ann N Y Acad Sci. 2007;1095:134-142.
18. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Cancer Res. 2007;67:3976-3985.
19. Kim SH, Oh JM, No JH, et al. Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. Carcinogenesis. 2009;30:753-757.
20. Simons AM, Mugica van Herckenrode C, Rodriguez JA, et al. Demonstration of smoking related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Br J Cancer. 1995;71:246.